ArticleInfection2018
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis.
Antonio Ascione et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it